ZNF280A

gene
On this page

Also known as 3'OY11.1ZNF636

Summary

ZNF280A (zinc finger protein 280A, HGNC:18597) is a protein-coding gene on chromosome 22q11.22, encoding Zinc finger protein 280A (P59817). May function as a transcription factor.

This gene encodes a zinc finger protein. The encoded protein contains 4 C2H2-type zinc fingers, which are commonly found in transcription factors. A variety of functions may be performed by this type of zinc finger protein, including the binding of DNA or RNA.

Source: NCBI Gene 129025 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 2 total
  • MANE Select transcript: NM_080740

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18597
Approved symbolZNF280A
Namezinc finger protein 280A
Location22q11.22
Locus typegene with protein product
StatusApproved
Aliases3’OY11.1, ZNF636
Ensembl geneENSG00000169548
Ensembl biotypeprotein_coding
Entrez129025

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000302097

RefSeq mRNA: 1 — MANE Select: NM_080740 NM_080740

CCDS: CCDS13800

Canonical transcript exons

ENST00000302097 — 2 exons

ExonStartEnd
ENSE000011353912251373622515701
ENSE000012561532252008922520270

Expression profiles

Bgee: expression breadth broad, 11 present calls, max score 88.42.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4499 / max 68.3181, expressed in 155 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1932770.4499155

Top tissues by expression

124 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047388.42gold quality
right adrenal gland cortexUBERON:003582764.64gold quality
left adrenal glandUBERON:000123463.98gold quality
right adrenal glandUBERON:000123362.83gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099162.14gold quality
left adrenal gland cortexUBERON:003582562.06gold quality
adrenal glandUBERON:000236959.05gold quality
stromal cell of endometriumCL:000225541.19silver quality
placentaUBERON:000198737.90gold quality
colonic epitheliumUBERON:000039737.20gold quality
endometriumUBERON:000129536.90gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
ganglionic eminenceUBERON:000402335.49gold quality
apex of heartUBERON:000209835.38gold quality
sural nerveUBERON:001548835.27gold quality
granulocyteCL:000009434.92gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
vermiform appendixUBERON:000115432.18gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
bone marrowUBERON:000237131.74gold quality
urinary bladderUBERON:000125531.70gold quality
muscle tissueUBERON:000238531.06gold quality
leukocyteCL:000073830.25gold quality
prefrontal cortexUBERON:000045130.16gold quality
monocyteCL:000057629.96gold quality
islet of LangerhansUBERON:000000629.70gold quality
liverUBERON:000210729.28gold quality
tonsilUBERON:000237228.96gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.26

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

15 targeting ZNF280A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-807599.9767.20962
HSA-MIR-7162-3P99.8968.161682
HSA-MIR-10393-3P99.7266.56961
HSA-MIR-6801-5P99.7266.50981
HSA-MIR-7154-5P99.6970.521900
HSA-MIR-443799.5265.291266
HSA-MIR-120699.3069.321016
HSA-MIR-5001-3P98.9167.281394
HSA-MIR-5088-5P97.9764.28487
HSA-MIR-6818-5P97.5067.101167
HSA-MIR-6726-5P95.9763.72841
HSA-MIR-92095.9763.95811
HSA-MIR-430095.8564.561003
HSA-MIR-5591-5P95.8564.761002
HSA-MIR-6874-5P95.7364.94545

Literature-anchored findings (GeneRIF, showing 2)

  • ZNF280A promotes lung adenocarcinoma development by regulating the expression of EIF3C. (PMID:33414445)
  • Knockdown of ZNF280A inhibits cell proliferation and promotes cell apoptosis of bladder cancer. (PMID:37345848)

Cross-species orthologs

0 orthologs

Paralogs (28): ZNF280C (ENSG00000056277), ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), PRDM12 (ENSG00000130711), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZBTB49 (ENSG00000168826), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZNF683 (ENSG00000176083), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB6 (ENSG00000186130), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)

Protein

Protein identifiers

Zinc finger protein 280AP59817 (reviewed: P59817)

Alternative names: 3’OY11.1, Suppressor of hairy wing homolog 1, Zinc finger protein 636

All UniProt accessions (1): P59817

UniProt curated annotations — full annotation on UniProt →

Function. May function as a transcription factor.

Subcellular location. Nucleus.

RefSeq proteins (1): NP_542778* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR013087Znf_C2H2_typeDomain
IPR025243DUF4195Domain
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050527

Pfam: PF13836

UniProt features (20 total): sequence variant 9, zinc finger region 4, compositionally biased region 4, region of interest 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P59817-F160.840.26

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 27 (showing top): DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP, YAGI_AML_WITH_11Q23_REARRANGED, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, HES2_TARGET_GENES, LCORL_TARGET_GENES, SNRNP70_TARGET_GENES, MIR6801_5P, MIR10393_3P, GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP, GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP, CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING

GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)

GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

378 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF280APOM121L1PQ3SYA9624
ZNF280AGGTLC2Q14390621
ZNF280AZNF200P98182595
ZNF280APRAMEP78395582
ZNF280AIQANK1A8MXQ7580
ZNF280AZNF668Q96K58565
ZNF280AZNF382Q96SR6511
ZNF280AOR1L3Q8NH93506
ZNF280AZNF84P51523504
ZNF280AOR1L1Q8NH94496
ZNF280ARIMBP3BA6NNM3446
ZNF280ACCDC71LQ8N9Z2446
ZNF280AZNF285Q96NJ3417
ZNF280AZNF276Q8N554407
ZNF280AHSFY1Q96LI6402

IntAct

22 interactions, top by confidence:

ABTypeScore
PDE4CZNF280Apsi-mi:“MI:0915”(physical association)0.560
ZNF280AENOPH1psi-mi:“MI:0915”(physical association)0.560
ZNF280Apsi-mi:“MI:0915”(physical association)0.560
ZNF280ACABP5psi-mi:“MI:0915”(physical association)0.560
ZNF280AEIF1ADpsi-mi:“MI:0915”(physical association)0.560
ZNF280APDE4Cpsi-mi:“MI:0915”(physical association)0.560
ZNF280AH2BC20Ppsi-mi:“MI:0915”(physical association)0.400
ZNF280ANUCB2psi-mi:“MI:0915”(physical association)0.400
ZNF280AKDM1Apsi-mi:“MI:0915”(physical association)0.370
ZNF280ANUCB2psi-mi:“MI:0914”(association)0.350
ZNF280Apsi-mi:“MI:0915”(physical association)0.000
ENOPH1ZNF280Apsi-mi:“MI:0915”(physical association)0.000
CABP5ZNF280Apsi-mi:“MI:0915”(physical association)0.000
EIF1ADZNF280Apsi-mi:“MI:0915”(physical association)0.000

BioGRID (31): ZNF280B (Affinity Capture-MS), NUCB2 (Affinity Capture-MS), HDGFRP3 (Affinity Capture-MS), RBM42 (Affinity Capture-MS), UPF3B (Affinity Capture-MS), ZNF280A (Two-hybrid), ZNF280A (Two-hybrid), ZNF280A (Two-hybrid), ZNF280A (Two-hybrid), ZNF280A (Two-hybrid), EIF1AD (Two-hybrid), CALM1 (Two-hybrid), ZNF280A (Proximity Label-MS), NUCB2 (Affinity Capture-MS), ZNF280A (Proximity Label-MS)

ESM2 similar proteins: A0A0R4IYX6, A0A1D5NVS8, A0AVK6, A4QP16, A5GFT6, A7XYJ6, B8A5Y1, D4A666, E1B7L7, E1BKK0, F1LMN3, F1QLG5, F1QZ88, F6NSX9, F7EA39, O73590, P12757, P59817, Q0VEE6, Q2IBF7, Q2TB10, Q53TQ3, Q566I1, Q58FA4, Q5R431, Q5ZIX8, Q60665, Q63679, Q68FE9, Q69ZF8, Q6IQ32, Q6P2L6, Q6PCM1, Q6ZSZ6, Q6ZU65, Q7Z3K3, Q80WC1, Q86UP3, Q8BHZ4, Q8BZH4

Diamond homologs: P59817, Q5PPG4, Q68FE8, Q6N043, Q6P3Y5, Q7Z3K3, Q86YH2, Q8BZH4, Q8ND82, Q99KZ6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

2 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance2
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

313 predictions. Top by Δscore:

VariantEffectΔscore
22:22520083:G:Cdonor_gain1.0000
22:22520178:T:TAdonor_gain1.0000
22:22517774:T:Cdonor_gain0.9900
22:22517778:AGAT:Adonor_gain0.9900
22:22520083:GCTCA:Gdonor_loss0.9900
22:22520084:CTCAC:Cdonor_loss0.9900
22:22520085:TCACC:Tdonor_loss0.9900
22:22520086:CA:Cdonor_loss0.9900
22:22520087:A:ACdonor_gain0.9900
22:22520087:A:ATdonor_loss0.9900
22:22520088:C:CCdonor_gain0.9900
22:22520088:C:Tdonor_loss0.9900
22:22520093:T:TAdonor_gain0.9800
22:22520088:CCAG:Cdonor_gain0.9600
22:22520087:AC:Adonor_gain0.9400
22:22520088:CC:Cdonor_gain0.9400
22:22515702:C:Aacceptor_loss0.9100
22:22515703:T:Gacceptor_loss0.9100
22:22516501:C:Adonor_gain0.9000
22:22515704:A:Cacceptor_loss0.8800
22:22515710:A:Tacceptor_loss0.8800
22:22516493:TGC:Tdonor_gain0.8800
22:22520082:AGCT:Adonor_gain0.8800
22:22520088:CCA:Cdonor_gain0.8800
22:22520088:CCAGT:Cdonor_gain0.8600
22:22515713:C:CTacceptor_loss0.8500
22:22516527:C:CAdonor_gain0.8400
22:22515712:CCA:Cacceptor_loss0.7700
22:22515716:G:Cacceptor_loss0.7000
22:22520090:AGTT:Adonor_gain0.6900

AlphaMissense

3605 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000277935 (22:22519104 A>G), RS1000873439 (22:22517155 C>T), RS1001326753 (22:22517356 G>A), RS1001955195 (22:22515312 C>G), RS1002004419 (22:22521520 T>C), RS1002058209 (22:22521805 G>A), RS1002183698 (22:22520482 C>T), RS1002286186 (22:22515847 A>G), RS1003518844 (22:22520657 G>A,T), RS1004112042 (22:22516288 C>T), RS1004846375 (22:22513599 C>T), RS1005116407 (22:22514828 T>C,G), RS1005578997 (22:22513488 C>CG), RS1005786395 (22:22521456 C>T), RS1006076608 (22:22520451 T>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009391_1468Metabolite levels9.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0010406triacylglycerol 48:3 measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

21 total (human), top 21 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, decreases expression, affects expression, decreases methylation, increases expression8
Benzo(a)pyreneincreases methylation, affects methylation, increases expression3
entinostatdecreases expression, affects cotreatment2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
methylmercuric chlorideincreases expression1
trichostatin Adecreases expression, increases expression1
butyraldehydeincreases expression1
S-(1,2-dichlorovinyl)cysteineaffects response to substance, increases expression, affects cotreatment, decreases expression1
CGP 52608affects binding, increases reaction1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
dorsomorphinaffects cotreatment, decreases expression1
(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)increases expression1
jinfukangaffects cotreatment, increases expression1
Leflunomidedecreases expression1
Cisplatinaffects cotreatment, increases expression1
Lipopolysaccharidesdecreases expression, affects response to substance, increases expression, affects cotreatment1
Quercetinincreases expression1
Urethaneincreases expression1
Cyclosporineincreases expression1
Aflatoxin B1affects expression1
Copper Sulfateincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.